Co-Authors
This is a "connection" page, showing publications co-authored by Hossein Khalili and Anahid Nourian.
Connection Strength
1.445
-
Sofosbuvir as a potential option for the treatment of COVID-19. Acta Biomed. 2020 May 11; 91(2):236-238.
Score: 0.881
-
Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed. 2020 11 10; 91(4):e2020102.
Score: 0.228
-
Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review. Iran J Kidney Dis. 2020 07; 14(4):247-255.
Score: 0.223
-
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020 Dec; 28(2):625-634.
Score: 0.056
-
Interferon ß-1b in treatment of severe COVID-19: A randomized clinical trial. Int Immunopharmacol. 2020 Nov; 88:106903.
Score: 0.056